Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 10/20 | 0.81 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.81 |
| ▸ | RAB9A | P51151 | 8/20 | 0.81 |
| ▸ | NPC1 | O15118 | 7/20 | 0.81 |
| ▸ | APP | P05067 | 5/20 | 0.81 |
| ▸ | GLA | P06280 | 5/20 | 0.81 |
| ▸ | GAA | P10253 | 5/20 | 0.81 |
| ▸ | SNCA | P37840 | 1/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.66 |
| ▸ | HPGD | P15428 | 5/20 | 0.66 |
| ▸ | RORC | P51449 | 2/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.63 |
| ▸ | MEN1 | O00255 | 4/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.63 |
| ▸ | CASP3 | P42574 | 1/20 | 0.63 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.63 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.63 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.63 |
| ▸ | TP53 | P04637 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16623332 | 0.91 | MAPT (0.68) | MAPTKDM4ERAB9ANPC1APP | |
| SCHEMBL13453290 | 0.90 | APP (1.00) | MAPTKDM4ERAB9ANPC1APP | |
| SCHEMBL12355589 | 0.90 | MAPT (0.72) | MAPTKDM4ERAB9ANPC1APP | |
| SCHEMBL2244143 | 0.90 | APP (0.72) | MAPTKDM4ERAB9ANPC1APP | |
| SCHEMBL5349180 | 0.90 | MAPT (0.72) | MAPTKDM4ERAB9ANPC1APP | |
| SCHEMBL492713 | 0.90 | APP (1.00) | MAPTKDM4ERAB9ANPC1APP | |
| SCHEMBL2950103 | 0.90 | APP (0.72) | MAPTKDM4ERAB9ANPC1APP | |
| SCHEMBL507097 | 0.89 | MAPT (0.71) | MAPTKDM4ERAB9ANPC1APP | |
| SCHEMBL14205633 | 0.89 | APP (0.65) | MAPTKDM4ERAB9ANPC1APP | |
| SCHEMBL13484314 | 0.89 | APP (0.70) | MAPTKDM4ERAB9ANPC1APP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12018128-B2 | Particle-dispersed polyimide precursor solution, method for producing porous polyimide film, and porous polyimide film | FUJIFILM BUSINESS INNOVATION CORP. (JP) | 2024-06-25 | — | — | US | disclosed |
| US-20220119596-A1 | PARTICLE-DISPERSED POLYIMIDE PRECURSOR SOLUTION, METHOD FOR PRODUCING POROUS POLYIMIDE FILM, AND POROUS POLYIMIDE FILM | FUJIFILM BUSINESS INNOVATION CORP. (JP) | 2022-04-21 | — | — | US | disclosed |
| US-11034797-B2 | Polyimide precursor composition, use thereof and polyimide made therefrom | ETERNAL MATERIALS CO., LTD. (TW) | 2021-06-15 | — | — | US | disclosed |
| US-20210079161-A1 | POLYIMIDE PRECURSOR COMPOSITION, USE THEREOF AND POLYIMIDE MADE THEREFROM | ETERNAL MATERIALS CO., LTD. (TW) | 2021-03-18 | — | — | US | disclosed |
| WO-2020046991-A1 | FASCIN BINDING COMPOUNDS FOR SPINOGENESIS | SPINOGENIX, INC. (US) | 2020-03-05 | — | — | WO | disclosed |
| US-20180134714-A1 | COMPOUNDS AND METHODS OF TREATING OCULAR DISORDERS | CASE WESTERN RESERVE UNIVERSITY | 2018-05-17 | — | — | US | disclosed |
| US-9864322-B2 | Image forming apparatus | RICOH COMPANY, LTD. (JP) | 2018-01-09 | — | — | US | disclosed |
| US-9714219-B2 | Sulfonylaminobenzamide compounds | NOVARTIS TIERGESUNDHEIT AG (CH) | 2017-07-25 | — | — | US | disclosed |
| US-20160363886-A1 | IMAGE FORMING APPARATUS | RICOH COMPANY, LTD. (JP) | 2016-12-15 | — | — | US | disclosed |
| US-20160363886-A1 | IMAGE FORMING APPARATUS | RICOH COMPANY, LTD. (JP) | 2016-12-15 | — | — | US | disclosed |
| US-7403735-B2 | Image formation apparatus using an electrophotographic process | RICOH COMPANY, LTD. (JP) | 2008-07-22 | — | — | US | disclosed |
| US-7375222-B2 | 2,4,6-Triamino-1,3,5-triazine derivative | ASTELLAS PHARMA INC. (JP) | 2008-05-20 | — | — | US | disclosed |
| US-7375222-B2 | 2,4,6-Triamino-1,3,5-triazine derivative | ASTELLAS PHARMA INC. (JP) | 2008-05-20 | — | — | US | disclosed |
| US-7365359-B2 | Organic semiconductor material and organic semiconductor element | DAI NIPPON PRINTING CO., LTD. (JP) | 2008-04-29 | — | — | US | disclosed |
| EP-1689717-B1 | SUBSTITUTED ISOQUINOLINES USEFUL IN THE TREATMENT OF DISEASES SUCH AS CANCER AND ATHEROSCLEROSIS | GLAXO GROUP LTD (GB) | 2007-12-26 | — | — | EP | disclosed |
| US-7255938-B2 | Organic electroluminescent device and organic compound for use in organic electroluminescent device | SANYO ELECTRIC CO., LTD. (JP) | 2007-08-14 | — | — | US | disclosed |
| US-7183409-B2 | Basic mono- and bisazo compounds | CLARIANT FINANCE (BVI) LIMITED (VG) | 2007-02-27 | — | — | US | disclosed |
| US-7183409-B2 | Basic mono- and bisazo compounds | CLARIANT FINANCE (BVI) LIMITED (VG) | 2007-02-27 | — | — | US | disclosed |
| US-7175958-B2 | Electrophotographic photoconductor, process for forming an image, image forming apparatus and process cartridge for the same | RICOH COMPANY, LTD. (JP) | 2007-02-13 | — | — | US | disclosed |
| US-7175958-B2 | Electrophotographic photoconductor, process for forming an image, image forming apparatus and process cartridge for the same | RICOH COMPANY, LTD. (JP) | 2007-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180134714-A1 | COMPOUNDS AND METHODS OF TREATING OCULAR DISORDERS | ALDH1A2, NR2E3, LRAT | MAPT 755/4885KDM4E 4118/4885RAB9A 432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.